Tango Therapeutics TNGX Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's retained earnings?
- Tango Therapeutics (TNGX) reported retained earnings of -$648.67M in Q1 2026.
- How has Tango Therapeutics's retained earnings changed year-over-year?
- Tango Therapeutics's retained earnings decreased by 19.8% year-over-year, from -$541.43M to -$648.67M.
- What is the long-term trend for Tango Therapeutics's retained earnings?
- Over 5 years (2020 to 2025), Tango Therapeutics's retained earnings has grown at a 42.4% compound annual growth rate (CAGR), from -$103.1M to -$603.15M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.